CiteScore measures average citations received per document published in the serial.
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
Overview | |
Publisher | MARY ANN LIEBERT, INC |
Language | English |
Frequency | Quarterly |
General Details | |
Language | English |
Frequency | Quarterly |
Publication Start Year | 2013 |
Publisher URL | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper238 articles received 3.2k citations see all
Human Gene Therapy Clinical Development has been in operation since 2013 till date.
Human Gene Therapy Clinical Development published with a Quarterly frequency.
In 2023, Human Gene Therapy Clinical Development published articles.
For Human Gene Therapy Clinical Development,eISSN is 2324-8645 and pISSN is2324-8637.
Citescore for Human Gene Therapy Clinical Development is 1.85.
H index for Human Gene Therapy Clinical Development is 16.
SNIP score for Human Gene Therapy Clinical Development is 0.6.
MARY ANN LIEBERT, INC is the publisher of Human Gene Therapy Clinical Development.